The Patent Finder

Adamas Pharma, LLC

Also on record
Records under this name other than the patents Adamas Pharma, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 12 patents it holds.

Back to Adamas Pharma, LLC

PatentTitleStatus Expires Confidence
US 8,389,578Composition and Method for Treating Neurological Disease
In force
 · High confidence
In forceHigh confidence
US 8,058,291Methods and Compositions for the Treatment of Cns-Related Conditions
In force
 · High confidence
In forceHigh confidence
US 8,168,209Method and Composition for Administering an Nmda Receptor Antagonist to a Subject
Term ended
Term ended Jul 18, 2026 · High confidence
Term endedTerm ended Jul 18, 2026High confidence
US 8,796,337Composition and Method for Treating Neurological Disease
Term ended
Term ended Nov 23, 2025 · High confidence
Term endedTerm ended Nov 23, 2025High confidence
US 8,889,740Composition and Method for Treating Neurological Disease
Term ended
Ended no later than Nov 23, 2025 · Medium confidence
Term endedEnded no later than Nov 23, 2025Medium confidence
US 8,895,614Composition and Method for Treating Neurological Disease
Term ended
Ended no later than Nov 23, 2025 · Medium confidence
Term endedEnded no later than Nov 23, 2025Medium confidence
US 8,895,615Composition and Method for Treating Neurological Disease
Term ended
Ended no later than Nov 23, 2025 · Medium confidence
Term endedEnded no later than Nov 23, 2025Medium confidence
US 8,895,616Composition and Method for Treating Neurological Disease
Term ended
Term ended Nov 23, 2025 · High confidence
Term endedTerm ended Nov 23, 2025High confidence
US 8,895,617Composition and Method for Treating Neurological Disease
Term ended
Ended no later than Nov 23, 2025 · Medium confidence
Term endedEnded no later than Nov 23, 2025Medium confidence
US 8,895,618Composition and Method for Treating Neurological Disease
Term ended
Ended no later than Nov 23, 2025 · Medium confidence
Term endedEnded no later than Nov 23, 2025Medium confidence
10 of 50 records shown.
Pro members see all 50.
Pro members: see all 50 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited